Skip to main content
Triochem Products Ltd. logo

Triochem Products Ltd. — Investor Relations & Filings

Ticker · 512101 ISIN · INE331E01013 BSE.NS Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2023-08-18 Regulatory Filings
Country IN India
Listing BSE.NS 512101

About Triochem Products Ltd.

https://www.triochemproducts.com

Triochem Products Ltd. is a manufacturer and exporter specializing in Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds for the global healthcare and pharmaceutical sectors. Its core product portfolio includes a range of specialized substances such as Quinine salts, Quinidine salts, and other niche therapeutic ingredients. Triochem Products Ltd. emphasizes adherence to stringent quality control measures and international regulatory standards to ensure the efficacy and safety of its chemical outputs. The organization serves a diverse clientele, providing essential raw materials for the formulation of various medications. By leveraging advanced chemical synthesis processes and technical expertise, the company maintains a significant presence in the supply chain for specialized pharmaceutical components.

Recent filings

Filing Released Lang Actions
In compliance with Regualtion 47 of SEBI (LOSR) Regiulation, 2015; Extract of newspaper copy of Unaudited Standalone Financial Results for the quarter ended June 30, 2023; published in ....
Regulatory Filings Classification · 95% confidence The document is a letter from Triochem Products Limited addressed to BSE Limited, referencing compliance with Regulation 47 of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. It mentions the enclosure of an extract of the newspaper publication of Unaudited Financial Results for the quarter ended June 30, 2023, which was approved by the Board on August 14, 2023. The document is an intimation or announcement regarding the publication of financial results, not the full financial report itself. The length is about 15,000 characters, but the content is primarily an announcement of the results being published in newspapers, not the detailed financial statements or analysis. Therefore, according to the "Menu vs Meal" rule, this is an announcement of a report, not the report itself. The appropriate classification is Regulatory Filings (RNS), as it is a regulatory announcement about the publication of quarterly financial results extract, not the full Interim/Quarterly Report (IR).
2023-08-18 English
Please find enclosed herewith the above statement for the quarter ened 30th June 2023
Regulatory Filings Classification · 100% confidence The document text is extremely short (188 characters) and contains only digital signature information without any substantive content or financial data. There is no indication of a report, announcement, or detailed filing. Given the lack of content, this document does not fit any specific report category and is best classified as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous filings without substantive content.
2023-08-14 English
We refer to our letter dated 5th August 2023 on the captioned subject. Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regualtion, 2015 and ....
Regulatory Filings
2023-08-14 English
We would like to inform you that, pursuant to Notice of Board meeting dated 5th August 2023 the Board Meeting of the Company was held today Monday 14th August 2023 at 2.00 p.m. at 4th Floor, ....
Regulatory Filings
2023-08-14 English
In Compliance to Regulation 47 of SEBI (LODR) Regulation, 2015. Copies of the Notice of the ensuring Board Meeting of the Company schedule to be held on Monday, 14th August 2023, publised ....
Regulatory Filings Classification · 95% confidence The document is a letter from Triochem Products Limited addressed to BSE Limited, referencing compliance with Regulation 47 of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. It mentions the publication of a Notice of an upcoming Board Meeting scheduled for 14th August 2023, and encloses copies of the Notice published in newspapers. The content is primarily an announcement of the Notice of a Board Meeting, not the meeting materials or minutes themselves. The document length is about 15,000 characters, but the content is focused on informing the stock exchange about the publication of the Notice, which is a regulatory announcement. There is no financial data, management discussion, or detailed report content. Therefore, this document fits best as a Regulatory Filing (RNS) because it is a compliance announcement under SEBI regulations about the Notice publication, not the actual report or meeting materials.
2023-08-07 English
TRIOCHEM PRODUCTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve 1 ) Consider and approve ....
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve the unaudited financial results for the quarter ended 30th June 2023. It is an intimation under SEBI regulations about the meeting date and agenda, not the financial results report itself. The document length is short (2101 characters) and it does not contain any financial data or analysis, only an announcement of the meeting and the agenda. Therefore, it is not an Interim/Quarterly Report (IR) but rather a Regulatory Filing (RNS) as a general regulatory announcement about the board meeting and financial results approval.
2023-08-05 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.